Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

How HIV works news

Show

From To
Four big insights into HIV/AIDS that provide hope of finding a vaccine

African researchers have been performing cutting-edge research to contribute to addressing the HIV epidemic. The sub-Saharan African Network for TB/HIV Research Excellence has been at the forefront of this research and has provided some important insights into how the virus spreads as well as the immune mechanisms that enable some people to control the virus without antiretroviral drugs.

Published
24 November 2017
From
The Conversation
Role of the Microbiome on HIV Infection, Prevention, and Treatment

The understanding of the human microbiome continues to grow rapidly. Innumerable projects have been launched worldwide to understand the role that the microbiome plays and its impact on human health. However, information on the role of the microbiome on HIV infection, prevention, and treatment is still limited. Interview with Nichole Klatt, PhD, associate professor in the department of pharmaceutics at University of Washington in Seattle.

Published
23 November 2017
From
Infectious Disease Advisor
How the Gut Microbiome Affects Outcomes in HIV

Gut microbiome alterations have been associated with frailty in older individuals. The journal HIV and Aging has published an article that discusses how aging and HIV affect the gut microbiome, and what impacts these factors have on health.

Published
14 November 2017
From
Specialty Pharmacy Times
Scientists find missing clue to how HIV hacks cells to propagate itself

Computer modeling has helped a team of scientists, including several scholars from the University of Chicago, to decode previously unknown details about the process by which HIV forces cells to spread the virus to other cells. The findings, published Nov. 7 in Proceedings of the National Academy of Sciences, may offer a new avenue for drugs to combat the virus.

Published
09 November 2017
From
University of Chicago News
HIV virus fighter linked to cancer mutations

University of Saskatchewan researchers have found the onset of breast, lung and other cancers may be connected to malfunctions of the immune system as it combats specific viruses such as HIV.

Published
26 October 2017
From
University of Saskatchewan
New Study Reveals why people with HIV are more likely to develop Emphysema

Up to 30 percent of HIV patients who are appropriately treated with antiretroviral therapies develop the chronic lung disease emphysema in their lifetime. Now, new research from Weill Cornell Medicine investigators has uncovered a mechanism that might explain why this lung damage occurs.

Published
10 May 2017
From
Weill Cornell Medicine
Pretreatment HIV, immune activation levels determine their persistence during treatment

A study led by a Massachusetts General Hospital investigator finds that pretreatment levels of HIV and immune activation appear to determine the extent to which viral levels and inflammation persist during antiretroviral treatment.

Published
25 April 2017
From
Eurekalert Inf Dis
HIV’s milder cousin may be less mild than previously thought

HIV-2’s virulence may have been underestimated and although progression to AIDS  and death in HIV-2 infection was slower than with HIV-1, it was the rule

Published
02 March 2017
By
Gus Cairns
Body's 'clever' protein could stop HIV in its tracks, scientists find

The weapon is a protein, found in the reproductive tract of women, which researchers from Hudson Institute of Medical Research and Deakin University have discovered stops HIV from replicating and taking hold.

Published
28 February 2017
From
The Sydney Morning Herald
Gut bacteria affect immune recovery in HIV patients, study finds

Gut bacteria also play their role in the immune recovery of HIV patients, an international study has found. The implications of this finding are that new complementary therapies could be developed that target these bacteria to boost the efficiency of ART and prevent the complications associated with immune deficiency and chronic inflammation.

Published
06 September 2016
From
Science Daily
← First12345...33Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.